Search

Search results

262 results found

Comparability of Event Adjudication Versus Administrative Billing Claims for Outcome Ascertainment in the DAPT Study: Findings From the EXTEND-DAPT Study.

Faridi, Kamil F, Hector Tamez, Neel M Butala, Yang Song, Changyu Shen, Eric A Secemsky, Laura Mauri, Jeptha P Curtis, Jordan B Strom, and Robert W Yeh. 2021. “Comparability of Event Adjudication Versus Administrative Billing Claims for Outcome Ascertainment in the DAPT Study: Findings From the EXTEND-DAPT Study.”. Circulation. Cardiovascular Quality and Outcomes 14 (1): e006589.

Call to Action to Prevent Venous Thromboembolism in Hospitalized Patients: A Policy Statement From the American Heart Association.

Henke, Peter K, Susan R Kahn, Christopher J Pannucci, Eric A Secemksy, Natalie S Evans, Alok A Khorana, Mark A Creager, Aruna D Pradhan, and American Heart Association Advocacy Coordinating Committee. 2020. “Call to Action to Prevent Venous Thromboembolism in Hospitalized Patients: A Policy Statement From the American Heart Association.”. Circulation 141 (24): e914-e931.

Cost-effectiveness analysis of short-duration dual antiplatelet therapy with newer drug-eluting stent platforms versus longer-duration dual antiplatelet therapy with a second-generation drug-eluting stent in elective percutaneous coronary intervention.

Galper, Benjamin Z, Matthew R Reynolds, Pallav Garg, Eric A Secemsky, Linda R Valsdottir, David J Cohen, and Robert W Yeh. 2019. “Cost-Effectiveness Analysis of Short-Duration Dual Antiplatelet Therapy With Newer Drug-Eluting Stent Platforms versus Longer-Duration Dual Antiplatelet Therapy With a Second-Generation Drug-Eluting Stent in Elective Percutaneous Coronary Intervention.”. Coronary Artery Disease 30 (3): 177-82.